Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,038 | 59,067 | 51,699 | 60,501 | 71,902 |
| Marketable Securities | 97,366 | 64,386 | N/A | N/A | N/A |
| Receivables | 2,618 | 622 | 898 | 784 | 732 |
| TOTAL | $141,018 | $124,806 | $53,807 | $62,164 | $73,915 |
| Non-Current Assets | |||||
| PPE Net | 7,246 | 3,813 | 2,824 | 2,540 | 2,277 |
| Investments And Advances | 170,127 | 171,500 | 21,500 | 11,500 | 10,000 |
| Intangibles | 24,538 | 24,649 | 16,605 | 54,431 | 28,398 |
| Other Non-Current Assets | 590 | 527 | 38,080 | 622 | 26,951 |
| TOTAL | $202,501 | $200,489 | $79,009 | $69,093 | $67,626 |
| Total Assets | $343,519 | $325,295 | $132,816 | $131,257 | $141,541 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,835 | 4,722 | 4,613 | 4,537 | 3,316 |
| Accounts payable and accrued liabilities | 13,339 | 15,474 | 2,474 | 1,886 | 1,656 |
| Accrued Expenses | 6,288 | 4,898 | 2,327 | 2,039 | 2,692 |
| Other current liabilities | 5,520 | N/A | N/A | N/A | N/A |
| TOTAL | $30,873 | $26,067 | $10,361 | $9,404 | $9,557 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,394 | 5,646 | 6,868 | 7,656 | 8,830 |
| Deferred Revenues | 891 | 973 | 947 | 942 | 1,893 |
| Other Non-Current Liabilities | 10,184 | 1,641 | 21,849 | 1,033 | 10,912 |
| TOTAL | $171,708 | $152,443 | $31,201 | $21,853 | $23,271 |
| Total Liabilities | $202,581 | $178,510 | $41,562 | $31,257 | $32,828 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,366 | 37,767 | 37,762 | 36,265 | 36,206 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -113,329 | -89,853 | -88,914 | -77,956 | -67,518 |
| Other shareholders' equity | 69,365 | 54,982 | 0 | 0 | 0 |
| TOTAL | $140,938 | $146,785 | $91,254 | $100,000 | $108,713 |
| Total Liabilities And Equity | $343,519 | $325,295 | $132,816 | $131,257 | $141,541 |